Cleared Special

K072979 - SPIROBANK G

K072979 is an FDA 510(k) clearance for SPIROBANK G, manufactured by Mir Medical Intl. Research Srl. The device is a Class 2 Anesthesiology device with product code BZG cleared through the Special 510(k) pathway after a 65-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
65d
Days
Class 2
Risk

K072979 is an FDA 510(k) clearance for the SPIROBANK G. Classified as Spirometer, Diagnostic (product code BZG), Class II - Special Controls.

Submitted by Mir Medical Intl. Research Srl (Roma, IT). The FDA issued a Cleared decision on December 26, 2007 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1840 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K072979

510(k) Number K072979 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 22, 2007
Decision Date December 26, 2007
Days to Decision 65 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 140d · This submission: 65d
Pathway characteristics
Modification to existing cleared device.

BZG Device Classification - Class 2, Special Controls

Product Code BZG Spirometer, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZG Spirometer, Diagnostic

All 158
Devices cleared under the same product code (BZG) and FDA review panel - the closest regulatory comparables to K072979.
MODIFICATION TO MINISPIR, SPIROLAB III
K082766 · Mir Medical Intl. Research Srl · Dec 2008
VITALOGRAPH MODEL 4000 (ASMA-1 AND COPD-6)
K073155 · Vitalograph (Ireland) , Ltd. · Jun 2008
MEDDORNA WIRELESS PRN SPIROMETER 100
K072722 · Meddorna, LLC · Apr 2008
ASTRA 300
K061571 · Sdi Diagnostics, Inc. · Jan 2007
ASTRAGUARD PULMONARY FUNCTION FILTER
K062913 · Sdi Diagnostics, Inc. · Jan 2007
PULMOLIFE
K061283 · Micro Medical, Ltd. · Dec 2006